It was delightful to speak to Editorial Board member Peter J Barnes at ERS 2019 in Madrid about chronic obstructive pulmonary disease as a disease of accelerated lung ageing.
1. What are the main similarities between ageing lungs and the lungs of chronic obstructive pulmonary disease (COPD) patients? (0:07)
2. What have these similarities taught us about the pathogenesis of COPD? (0:34)
3. Which ageing-related molecular pathways are the most promising therapeutic targets for COPD? (1:02)
4. How can we use these ageing parameters to predict which patients are most likely to develop COPD? (1:51)
5. What other chronic lung diseases show signs of accelerated lung ageing? (2:23)
Speaker disclosures: Peter J Barnes has received research funding from AstraZeneca and Boehringer Ingelheim, advisory board/consultancy fees for AstraZeneca, Boehringer Ingelheim, Novartis, Pieris. He has been a speaker for AstraZeneca, Boehringer Ingelheim, Novartis, Teva.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.
Share this Video
Related Videos In COPD
Donald Mahler, CHEST 2021: Precision Medicine in COPD
We were delighted to speak with Prof. Donald Mahler (Geisel School of Medicine, Dartmouth, NH, USA) to explore his presentation ‘Precision Medicine in COPD’, which was presented at CHEST 2021, 17-20 October 2021. Questions What is the limitation of traditional approaches to the treatment of COPD? (0:26) What are the major challenges of moving to […]
Douglas Mapel, ATS 2021: The Rate of ED Visits in Patients with COPD in the IMPACT Trial
It was a pleasure to meet with Dr Douglas Mapel (Northern Arizona Pulmonary Associates – Critical Care, Flagstaff, AZ, US) to talk around his abstract on ‘Reduction in Emergency Department (ED) Visits in Patients with Chronic Obstructive Pulmonary Disease (COPD): Analysis of the IMPACT Trial.‘, which was presented at ATS 2021 International Conference, 14-19 May, […]
Brian Carlin, CHEST 2020 – New Thoughts in COPD
Brian Carlin (Pittsburgh Critical Care Associates, Pittsburgh, PA, US) talks to us about recent developments in the treatment of COPD and the impact COVID-19 has had on pulmonary rehabilitation services. Questions 1. What have been the most exciting recent developments in inhaled therapies for COPD? (0:20) 2. What factors should physicians consider before prescribing inhaled […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!